Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.04
Delayed Data
As of Sep 01
 0.00 / 0.00%
Today’s Change
2.50
Today|||52-Week Range
8.47
-36.13%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close3.04
Today’s open2.95
Day’s range2.94 - 3.10
Volume59,985
Average volume (3 months)108,697
Market cap$56.2M
Dividend yield--
Data as of 09/01/2015

Growth & Valuation

Earnings growth (last year)-51.11%
Earnings growth (this year)+16.18%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.96

Competitors

 Today’s
change
Today’s
% change
PBMDPrima BioMed Ltd+0.29+24.37%
--Protea Biosciences G...0.000.00%
IMUCImmunoCellular Thera...+0.00+0.07%
HTGMHTG Molecular Diagno...+0.27+4.94%
Data as of 1:57pm ET, 09/01/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$9.2M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
Chief Executive Officer
Anthony S. Fiorino
President
Chaim Lebovits
Corporate headquarters
Hackensack, New Jersey

Forecasts

Partner Offers